Epidermal growth factor biosimilar (RAS Lifesciences)

人表皮生长因子生物类似药 (RAS Lifesciences)

Report date: 2022/01/14 13:23:58

Base Information

Drug NameEpidermal growth factor biosimilar (RAS Lifesciences)
Drug Alias Name人表皮生长因子生物仿制药 (RAS Lifesciences)
ClassificationBiologics > Biosimilar
Mechanisms of ActionEpidermal growth factor receptor erbB1 agonists
TargetsEpidermal growth factor receptor erbB1
Therapy Area/IndicationsN/A
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryIndia
Original Approved Date2012/10/01
Country/TerritoryIndia
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaN/A
Originator CompaniesRas Lifesciences
China Registration ClassN/A

Develop Information

Active CompaniesRas Lifesciences
Inactive CompaniesN/A
Active IndicationsN/A
Inactive IndicationsN/A

Other Information

ATC CodeD03
Related LinksN/A